Stoneridge Investment Partners LLC Tg Therapeutics, Inc. Transaction History

Stoneridge Investment Partners LLC

  • $269 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021
SELL
$25.27 - $54.9 $203,196 - $441,450
-8,041 Closed
0 $0
Q3 2020

Oct 28, 2020
BUY
$18.49 - $27.24 $148,678 - $219,036
8,041 New
8,041 $215,000
Q2 2018

Jul 31, 2018
SELL
$12.5 - $15.0 $702,200 - $842,640
-56,176 Closed
0 $0
Q1 2018

Apr 27, 2018
SELL
$8.7 - $16.8 $137,651 - $265,809
-15,822 Reduced 21.98%
56,176 $798,000
Q3 2017

Nov 02, 2017
BUY
$10.0 - $12.7 $719,980 - $914,374
71,998
71,998 $853,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Stoneridge Investment Partners LLC Portfolio

Follow Stoneridge Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stoneridge Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email